期刊文献+

1-(1-乙基-1H-5-吲哚基)-2-苯基-1,2-二酮缩合成1,2,4-三嗪类化合物反应

Condensation of 1-(1-Ethyl-1H-indol-5-yl)-2-phenylethane-1,2-dione to 1,2,4-Triazines
原文传递
导出
摘要 报道了一种1-(1-乙基-1H-5-吲哚基)-2-苯基-1,2-二酮与氨基胍碳酸氢盐缩合生成互为同分异构体的两种1,2,4-三嗪的反应,并通过运用目标定向合成和核磁的方法,研究了1,2-二酮苯环上不同取代基对反应产品比例的影响.反应总收率为40%~81%,且当不对称1,2-二酮苯环上无取代基时,其生成的同分异构体6-(1-乙基-1H-5-吲哚基)-5-苯基-3-氨基-1,2,4-三嗪(2a)和5-(1-乙基-1H-5-吲哚基)-6-苯基-3-氨基-1,2,4-三嗪(4a)比例为40∶60;当苯环上取代基为吸电子基时,6-(1-乙基-1H-5-吲哚基)-5-(4-硝基苯基)-3-氨基-1,2,4-三嗪(2b)和5-(1-乙基-1H-5-吲哚基)-6-(4-硝基苯基)-3-氨基-1,2,4-三嗪(4b)比例为63∶37;当苯环上取代基为供电子基时,绝大部分生成2系列构型结构. This paper reports the selective condensation of aminoguanidine with 1-(1-ethyl-1H-indol-5-yl)-2-phenylethane-1,2-dione to afford 1,2,4-triazines. The constituents and relative proportion of these condensation products are identified by the methods of target-oriented synthesis and nuclear magnetic resonance. And the influences on the relative proportion by different substituents are described. When the phenyl is substituted with the electron-withdrawing group, the ratio of the isomers 6-(1-ethyl-1H-indol-5-yl)-5-phenyl-1,2,4-triazin-3-amine/5-(1-ethyl-1H-indol-5-yl)-6-phenyl-1,2,4-triazin-3-amine [n(2a) ∶n(4a)] is 40 ∶ 60; when without the substituent, the ratio of the isomers 6-(1-ethyl-1H-indol-5-yl)-5-(4-nitrophenyl)-1,2,4-triazin-3-amine/5-(1-ethyl-1H-indol-5-yl)-6-(4-nitrophenyl)-1,2,4-triazin-3-amine [n(2b)∶n(4b)] is 63∶37; when substituted with the electron-donating group, the type of the major products was 2.
出处 《有机化学》 SCIE CAS CSCD 北大核心 2016年第2期370-376,共7页 Chinese Journal of Organic Chemistry
关键词 缩合 不对称1 2-二酮 同分异构体 1 2 4-三嗪 condensation unsymmetrical 1 2-diketone isomer 1 2 4-triazine
  • 相关文献

参考文献12

  • 1陆忠娥,万军,陈克潜.3-氨基-5-取代苯氨基-6-苯基-1,2,4-三嗪的合成[J].有机化学,1992,12(6):605-607. 被引量:2
  • 2李英俊,邵昕,高立信,靳煜,盛丽,罗漳川,于洋,李佳.有机化学,2013,33,2178.
  • 3李英俊,史相玲,高立信,靳煜,盛丽,吴疆红,彭立娜,李佳,有机化学,2015,35,191.
  • 4Eid, M. M.; Mansour, A. K. J. Heterocycl. Chem. 1988, 25, 1139.
  • 5Rees, R. W. A.; Russell, E B.; Foell, T. J.; Bright, R. E. J. Med. Chem. 1972, 15, 859.
  • 6March, L. C.; Bajwa, G. S.; Lee, J.; Wasti, K.; Joullie, M. M. J. Med. Chem. 1976, 19, 845.
  • 7Kim, J. W.; Lee, D. Y.; Park, C. M. ACS Med Chem. Lett. 2012, 3, 678.
  • 8Congreve, M.; Andrews, S. P.; Dore, A. S.; Hollenstein, K. J. Med. Chem. 2012, 55, 1898.
  • 9Xie, F. C.; Zhao, H. B.; Li, D. W.; Chen, H.; Quan, H. T.; Shi, X. J.; Lou, L. G.; Hu, Y. H. J. Med. Chem. 2011, 54, 3200.
  • 10Mallikarjuna, B. P.; Suresh, K. G. V.; Sastry, B. S.; Nagaraj; Mano- hara, K. P. J. Zhejiang Univ., Sci. B 2007, 8, 526.

二级参考文献3

  • 1Xu L C,Chin Chem Lett,1991年,2卷,191页
  • 2陆忠娥,Chin Chem Lett,1991年,2卷,525页
  • 3陆忠娥,Chin Chem Lett,1990年,1卷,3期,205页

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部